Clinical Trial Update: Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of venetoclax, cytarabine, and metformin in relapsed/refractory or induction-ineligible acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Venetoclax (venetoclax)
• metformin (metformin)

Snippet

Sponsor: Hospital Municipal São José | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING